Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Cash (used in) provided by operating activities
Net loss	$ (52,870,000)	$ (23,009,000)	$ (4,071,000)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation	264,000	576,000	891,000
Amortization of intangible assets	2,134,000	0	0
Stock-based compensation	797,000	2,330,000	1,453,000
Noncash interest expense	2,676,000	0	0
Fair value change in contingent consideration (Notes 14, 16)	2,042,000	0	2,000,000
Unrealized foreign exchange gain (losses)	118,000	(120,000)	75,000
Loss (gain) on sale of long-lived assets	50,000	(36,000)	0
Fair value loss on investment (Note 4)	10,704,000	0	0
Deferred income taxes	(214,000)	18,000	(177,000)
Impairment of long-lived assets	0	11,000	0
Changes in assets and liabilities, excluding the effect of acquisition:
Accounts receivable	(893,000)	10,000	73,000
Inventories	2,079,000	0	0
Prepaid and other assets	705,000	442,000	810,000
Accounts payable	4,441,000	(184,000)	(607,000)
Accrued liabilities	(6,389,000)	570,000	108,000
Accrued restructuring	0	0	(130,000)
Income taxes receivable/payable	0	33,000	30,000
Net cash (used in) provided by operating activities	(34,356,000)	(19,359,000)	455,000
Cash provided by investing activities
Cash acquired through acquisition (Note 5)	28,290,000	0	0
Cash consideration for acquisition - loan to Aegerion (Note 5)	(3,000,000)	0	0
Proceeds from sale of long-lived assets	192,000	43,000	115,000
Purchases of property and equipment	(155,000)	(9,000)	(25,000)
Proceeds from contingent consideration (Notes 16)	0	0	36,582,000
Net cash provided by investing activities	25,327,000	34,000	36,672,000
Cash (used in) provided by financing activities
Issuance of common shares	21,481,000	5,508,000	509,000
Cash distribution paid to common shareholders	(15,000,000)	0	0
Settlement of Backstop Agreement (Note 4)	15,000,000	0	0
Aralez investment	(45,000,000)	0	0
Net cash (used in) provided by financing activities	(23,519,000)	5,508,000	509,000
Exchange rate effect on cash	(349,000)	(267,000)	(249,000)
Net (decrease) increase in cash and cash equivalents	(32,897,000)	(14,084,000)	37,387,000
Cash and cash equivalents, beginning of period	141,824,000	155,908,000	118,521,000
Cash and cash equivalents, end of period	108,927,000	141,824,000	155,908,000
Supplemental cash flow information
Cash paid for interest	33,000	0	0
Cash paid for taxes	105,000	0	0
Non-cash financing activities
Shares issued in the acquisition (Note 5)	59,088,000	0	0
Convertible notes of Aegerion, at fair value (Note 10)	222,900,000	0	0
Non-cash investment activities
Purchases of property and equipment included in accounts payable	$ 61,000	$ 0	$ 0